MX349690B - Polietilenglicol (peg) o copolimeros de bloqueo de bloque de polietilenglicol (peg) para el tratamiento de cancer colorrectal. - Google Patents

Polietilenglicol (peg) o copolimeros de bloqueo de bloque de polietilenglicol (peg) para el tratamiento de cancer colorrectal.

Info

Publication number
MX349690B
MX349690B MX2013004963A MX2013004963A MX349690B MX 349690 B MX349690 B MX 349690B MX 2013004963 A MX2013004963 A MX 2013004963A MX 2013004963 A MX2013004963 A MX 2013004963A MX 349690 B MX349690 B MX 349690B
Authority
MX
Mexico
Prior art keywords
peg
colorectal cancer
block copolymers
treating colorectal
treating
Prior art date
Application number
MX2013004963A
Other languages
English (en)
Spanish (es)
Other versions
MX2013004963A (es
Inventor
Cox Ian
Smith Samuel
Jones Leighton
Charlton Rachel
Stein Peter
Plessl Joerg
De Vries Corinne
Original Assignee
Norgine Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norgine Bv filed Critical Norgine Bv
Publication of MX2013004963A publication Critical patent/MX2013004963A/es
Publication of MX349690B publication Critical patent/MX349690B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
MX2013004963A 2010-11-04 2011-11-04 Polietilenglicol (peg) o copolimeros de bloqueo de bloque de polietilenglicol (peg) para el tratamiento de cancer colorrectal. MX349690B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1018650.0A GB201018650D0 (en) 2010-11-04 2010-11-04 Methods and compositions
US41212810P 2010-11-10 2010-11-10
PCT/GB2011/001561 WO2012059725A1 (en) 2010-11-04 2011-11-04 Peg or peg block copolymers for treating colorectal cancer

Publications (2)

Publication Number Publication Date
MX2013004963A MX2013004963A (es) 2013-08-27
MX349690B true MX349690B (es) 2017-08-09

Family

ID=43414365

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013004963A MX349690B (es) 2010-11-04 2011-11-04 Polietilenglicol (peg) o copolimeros de bloqueo de bloque de polietilenglicol (peg) para el tratamiento de cancer colorrectal.

Country Status (22)

Country Link
US (2) US20130216493A1 (https=)
EP (1) EP2635289B1 (https=)
JP (1) JP5917537B2 (https=)
KR (1) KR20130109171A (https=)
CN (1) CN103313719A (https=)
AR (1) AR083770A1 (https=)
AU (1) AU2011324996B2 (https=)
BE (1) BE1019494A3 (https=)
BR (1) BR112013011012A2 (https=)
CA (1) CA2816839A1 (https=)
EA (1) EA201300540A1 (https=)
ES (1) ES2401269B1 (https=)
GB (1) GB201018650D0 (https=)
MX (1) MX349690B (https=)
MY (1) MY163067A (https=)
NL (1) NL2007715C2 (https=)
NZ (1) NZ611145A (https=)
SG (1) SG189533A1 (https=)
TW (1) TWI606832B (https=)
UA (1) UA107998C2 (https=)
WO (1) WO2012059725A1 (https=)
ZA (1) ZA201304052B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
MX382868B (es) 2012-09-11 2025-03-13 Norgine Bv Composiciones que comprenden polietilenglicol y ascorbato.
AR093153A1 (es) * 2012-10-26 2015-05-20 Northshore Univ Healthsystem Composiciones que comprenden polietilenglicol para la terapia del carcinoma de celulas escamosas de cabeza y cuello
CN103083733A (zh) * 2013-02-19 2013-05-08 华熙福瑞达生物医药有限公司 一种医用体腔器械导入水性润滑剂
EP3934661B1 (en) 2019-03-05 2025-04-02 Dow Global Technologies LLC Inducing caspase activity for treating colorectal cancer with polymers
WO2020180555A1 (en) * 2019-03-05 2020-09-10 Dow Global Technologies Llc Polyethyleneglycol derivatives for inducing caspase activity
WO2020180581A1 (en) 2019-03-05 2020-09-10 Dow Global Technologies Llc Inducing caspase activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2784897B1 (fr) * 1998-10-27 2002-11-29 Agronomique Inst Nat Rech Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux
EP1877039A4 (en) * 2005-05-06 2010-08-18 Salix Pharmaceuticals Inc Polyethylene glycol GUT CLEANING COMPOSITION
US8457025B2 (en) * 2009-08-28 2013-06-04 Telefonaktiebolaget L M Ericsson (Publ) Method and network node for selecting a network prefix to be advertised in a communication network

Also Published As

Publication number Publication date
BE1019494A3 (fr) 2012-07-03
NL2007715A (en) 2012-05-07
AU2011324996A1 (en) 2013-05-02
GB201018650D0 (en) 2010-12-22
MY163067A (en) 2017-08-15
TW201304785A (zh) 2013-02-01
WO2012059725A1 (en) 2012-05-10
US20160228467A1 (en) 2016-08-11
MX2013004963A (es) 2013-08-27
EA201300540A1 (ru) 2013-09-30
NZ611145A (en) 2015-07-31
EP2635289B1 (en) 2020-03-11
KR20130109171A (ko) 2013-10-07
ES2401269B1 (es) 2014-02-19
AU2011324996B2 (en) 2015-10-08
WO2012059725A8 (en) 2013-05-30
TWI606832B (zh) 2017-12-01
UA107998C2 (uk) 2015-03-10
CA2816839A1 (en) 2012-05-10
ES2401269A1 (es) 2013-04-18
BR112013011012A2 (pt) 2016-08-23
CN103313719A (zh) 2013-09-18
NL2007715C2 (en) 2012-10-16
EP2635289A1 (en) 2013-09-11
JP2013544809A (ja) 2013-12-19
ZA201304052B (en) 2014-02-26
AR083770A1 (es) 2013-03-20
JP5917537B2 (ja) 2016-05-18
SG189533A1 (en) 2013-05-31
US20130216493A1 (en) 2013-08-22

Similar Documents

Publication Publication Date Title
MX349690B (es) Polietilenglicol (peg) o copolimeros de bloqueo de bloque de polietilenglicol (peg) para el tratamiento de cancer colorrectal.
EP4406557A3 (en) Materials and methods for improving gastrointestinal function
AP2013006813A0 (en) Pharmaceutical composition, methods for treating and uses thereof
MX360404B (es) Compuestos para inhibir la proliferacion celular en canceres transmitidos por egfr.
MX2013012387A (es) Composicion que comprende aflibercept, acido folinico, 5-fluorouracilo (5-fu) e irinocetan (folfiri).
MY159393A (en) Compositions for treating centrally mediated nausea and vomiting
WO2008094708A3 (en) Activin-actriia antagonists and uses for treating or preventing breast cancer
PH12015501088A1 (en) Dimeric compounds
WO2012078633A8 (en) Methods of inhibiting metastasis from cancer
IN2012DN02046A (https=)
HK1210962A1 (en) Methods for treatment of atherosclerosis
WO2009095261A3 (en) Vaccine compositions
EP2663576A2 (en) Novel wnt compositions and therapeutic uses of such compositions
PH12017502216A1 (en) Nucleic acid-cationic polymer compositions and methods of making and using the same
WO2011121576A3 (en) Immunogenic proteins and compositions for the treatment and prevention of streptococcus agalactiae
WO2012073047A3 (en) Compositions and methods
PH12013501311A1 (en) Polymer systems
MX2012013875A (es) Anticuerpos de union sparc en sangre periferica y usos de los mismos.
WO2009114461A3 (en) Angiotensin (1-7) dosage forms and uses thereof
WO2011100330A3 (en) Compositions and methods for preventing or treating a human parvovirus infection
WO2012017321A3 (en) Treatment for dyslipidemia
WO2012170742A3 (en) Treatment and prevention of cancer with hmgb1 antagonists
PH12015500399A1 (en) Azaindolines
WO2012074725A3 (en) Immunomodulatory methods and systems for treatment and/or prevention of hypertension
EA201301205A1 (ru) Способ предупреждения и/или лечения плоскоклеточного рака головы и шеи и композиция в нем используемая

Legal Events

Date Code Title Description
FG Grant or registration